Biomarkers in the field of obesity and its related comorbidities (Q38183431)

30 August 2017

title

Biomarkers in the field of obesity and its related comorbidities (English)

1 reference

30 August 2017

0 references

0 references

1 reference

Efthymia A Katsareli

1

1 reference

30 August 2017

George V Dedoussis

series ordinal

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

30 January 2014

1 reference

Expert Opinion on Therapeutic Targets

30 August 2017

published in

1 reference

30 August 2017

volume

18

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

385-401

1 reference

High adiposity and high body mass index-for-age in US children and adolescents overall and by race-ethnic group

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

New predictors of the metabolic syndrome in children--role of adipocytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The distinction of metabolically 'healthy' from 'unhealthy' obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Raised interleukin-6 levels in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Microalbuminuria--a biomarker of renal microvascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The human obese (OB) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The emerging role of adipokines as mediators of inflammation and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Leptin and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Leptin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Visfatin: the link between inflammation and childhood obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Low leptin gene expression and hyperleptinemia in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Role of leptin in blood pressure regulation and arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Disulfide-dependent multimeric assembly of resistin family hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

An update on the biology and physiology of resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Adenovirus-mediated high expression of resistin causes dyslipidemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Role of resistin in obesity, insulin resistance and Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Resistin, acute coronary syndrome and prognosis results from the AtheroGene study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Plasma resistin levels correlate with determinants of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Adiponectin differentially regulates cytokines in porcine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Inflamed adipose tissue, insulin resistance and vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Adipose tissue: a regulator of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The role of interleukins in insulin resistance and type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: interactive influence of 647 MT1a and -174 IL-6 polymorphic alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Visfatin: the missing link between intra-abdominal obesity and diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Serum visfatin levels, adiposity and glucose metabolism in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Elevated vaspin and leptin levels are associated with obesity in prepubertal Korean children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Serum vaspin concentrations in human obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Adipocytokines and the metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Chemerin: at the crossroads of inflammation and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral adipocytes from obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Chemerin is a novel adipokine associated with obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The role of the endocannabinoid system in the neuroendocrine regulation of energy balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Energy balance regulation by endocannabinoids at central and peripheral levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The case for peripheral CB1 receptor blockade in the treatment of visceral obesity and its cardiometabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Biomarkers of endocannabinoid system activation in severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Endocannabinoids measurement in human saliva as potential biomarker of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Apelin, diabetes, and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The lipocalin protein family: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Plasma retinol binding protein: structure and function of the prototypic lipocalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Cellular and molecular aspects of adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Obesity and the regulation of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

A Review of the Microcirculation of Adipose Tissue: Anatomic, Metabolic, and Angiogenic Perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Matrix metalloproteinases: effectors of development and normal physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Matrix metalloproteinase-2 and -9 levels in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

TNFalpha up-regulates apelin expression in human and mouse adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Obesity, adiponectin and vascular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Post-translational modifications of adiponectin: mechanisms and functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Obesity-associated hypertension and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Omentin plasma levels and gene expression are decreased in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Circulating omentin concentration increases after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Fat-derived Factor Omentin Stimulates Endothelial Cell Function and Ischemia-induced Revascularization via Endothelial Nitric Oxide Synthase-dependent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Circulating omentin is associated with coronary artery disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Identification of nesfatin-1 as a satiety molecule in the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Decreased Cerebrospinal Fluid/Plasma Ratio of the Novel Satiety Molecule, Nesfatin-1/NUCB-2, in Obese Humans: Evidence of Nesfatin-1/NUCB-2 Resistance and Implications for Obesity Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

A novel adipocytokine, nesfatin-1 modulates peripheral arterial contractility and blood pressure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Evidence for a role of endogenous nesfatin-1 in the control of water drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Nesfatin-1, corticotropin-releasing hormone, thyrotropin-releasing hormone, and neuronal histamine interact in the hypothalamus to regulate feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

21 January 2018

Vitamin D insufficiency.

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Vitamin D and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Lymphocide: cytokines and the control of lymphoid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Defective IL7R expression in T(-)B( )NK( ) severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Mutations in the gene for the IL-7 receptor result in T(-)B( )NK( ) severe combined immunodeficiency disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Potential contribution of IL-7 to allergen-induced eosinophilic airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Interleukin-7, a new cytokine targeting the mouse hypothalamic arcuate nucleus: role in body weight and food intake regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Interleukin-7 regulates adipose tissue mass and insulin sensitivity in high-fat diet-fed mice through lymphocyte-dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

IL-7 is essential for homeostatic control of T cell metabolism in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Interleukin-20 circulating levels in obese women: effect of weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Environmental and genetic factors influence the relationship between circulating IL-10 and obesity phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Magnetic resonance imaging determined visceral fat reduction associates with enhanced IL-10 plasma levels in calorie restricted obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

A potential role for interleukin-15 in the regulation of human natural killer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Oversecretion of interleukin-15 from skeletal muscle reduces adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Interleukin-15 treatment induces weight loss independent of lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic beta-cell destruction in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Childhood obesity is associated with changes in the serum metabolite profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Effects of interleukin-15 on lipid oxidation: disposal of an oral [(14)C]-triolein load

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Intracellular signalling pathways activated by leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Adipokines and Risk of Type 2 Diabetes in Older Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Chemerin as a Mediator between Obesity and Vascular Inflammation in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

Vitamin D Status is Linked to Biomarkers of Oxidative Stress, Inflammation, and Endothelial Activation in Obese Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2014.882321

10.1517/14728222.2014.882321

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference